ArticleCureus2025
Renal Sinus Angiomyolipoma: An Unusual Cause of a Pelvicalyceal Mass.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Renal angiomyolipomas (AMLs) are typically benign tumors of the renal cortex, often discovered incidentally. Although rare, AMLs can originate in the renal sinus and extend into the pelvicalyceal system, leading to obstructive uropathy and mimicking urothelial malignancies. We present the case of a 23-year-old female who was referred to our institution with right flank pain and hematuria. Imaging revealed a fat-containing mass in the right renal sinus extending into the pelvicalyceal system and causing ureteropelvic junction obstruction. A presumptive diagnosis of AML was made based on CT characteristics, which was later confirmed histopathologically following surgical excision. This case emphasizes the importance of recognizing the characteristic imaging features of AMLs, particularly in unusual locations, and highlights the role of biopsy in guiding conservative, nephron-sparing management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.